While osteonecrosis of the jaw (ONJ) is usually associated with osteoporosis therapies such as bisphosphonates, a new Australian study has revealed links to other medications such as immunomodulators and anti-angiogenic drugs. A review of more than 419 reports of medication-related ONJ in the TGA’s adverse reaction database found that most were related to denosumab (221) ...
Look beyond the usual suspects for ONJ-causing medications
By Michael Woodhead
3 Dec 2020